Cargando…

Diffuse large B cell lymphoma (DLBCL) in patients older than 65 years: analysis of 3 year Real World data of practice patterns and outcomes in England

BACKGROUND: We wished to examine treatment and outcome patterns in older diffuse large B-cell lymphoma (DLBCL) patients, with a focus on the effect of route-to-diagnosis to outcome. METHODS: Data were extracted from Public Health England’s National Cancer Registration and Analysis Service between 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hounsome, L., Eyre, T. A., Ireland, R., Hodson, A., Walewska, R., Ardeshna, K., Chaganti, S., McKay, P., Davies, A., Fox, C. P., Kalakonda, N., Fields, P. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727618/ https://www.ncbi.nlm.nih.gov/pubmed/34611308 http://dx.doi.org/10.1038/s41416-021-01525-4

Ejemplares similares

P1138: FIVE-YEAR EFFICACY AND SAFETY OF TAFASITAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY DLBCL: FINAL RESULTS FROM THE PHASE II L-MIND STUDY
por: Duell, Johannes, et al.
Publicado: (2023)

Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years
por: Jullien, Maxime, et al.
Publicado: (2021)

Avelumab in Combination Regimens for Relapsed/Refractory DLBCL: Results from the Phase Ib JAVELIN DLBCL Study
por: Hawkes, Eliza A., et al.
Publicado: (2021)

The Immunology of DLBCL
por: Takahara, Taishi, et al.
Publicado: (2023)

Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients
por: Wang, Jing, et al.
Publicado: (2016)

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England
por: van Hoek, Albert Jan, et al.
Publicado: (2016)

Applying probability calibration to ensemble methods to predict 2-year mortality in patients with DLBCL
por: Fan, Shuanglong, et al.
Publicado: (2021)

Sir Nevill Mott: 65 years in physics
por: Alexandrov, A S, et al.
Publicado: (1995)

Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study
por: Khan, Umair Tahir, et al.
Publicado: (2021)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

DLBCL Coast to Coast
por: Tesio, Melania
Publicado: (2018)

GOALs in relapsed DLBCL
por: Rösler, Wiebke, et al.
Publicado: (2022)

Clinical Outcomes After Cardiac Stress Testing Among US Patients Younger Than 65 Years
por: Kini, Vinay, et al.
Publicado: (2018)

American Society of Hematology 2020 Podcast Collection: FL and DLBCL
por: Fox, Christopher Paul, et al.
Publicado: (2021)

Differences in the presentation and evolution of primary aldosteronism in elderly (≥65 years) and young patients (<65 years)
por: Parra Ramírez, Paola, et al.
Publicado: (2022)

The epidemiology of bone cancer in 0 - 39 year olds in northern England, 1981 - 2002
por: Eyre, Rachel, et al.
Publicado: (2010)

Comparison of long-term outcome between patients aged < 65 years vs. ≥ 65 years after atrial fibrillation ablation
por: Kis, Zsuzsanna, et al.
Publicado: (2017)

HIV infection in elderly (patients aged more than 65 years)
por: Almasi, Farahnaz
Publicado: (2010)

Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL
por: Northend, Michael, et al.
Publicado: (2022)

Evaluation of Inappropriate Prescribing in Patients Older than 65 Years in Primary Health Care
por: Nuñez-Montenegro, Antonio, et al.
Publicado: (2019)

Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
por: Boustani, M. A., et al.
Publicado: (2016)

Dialysis outcomes in those aged ≥65 years
por: Walker, Robert, et al.
Publicado: (2013)

Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters
por: Ritter, Zsombor, et al.
Publicado: (2022)

65‐year‐old woman with hematemesis
por: Yen, Chieh‐Ching, et al.
Publicado: (2021)

Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD‐11 trial
por: Frias, Juan P., et al.
Publicado: (2021)

Psychiatric causes of behavioural change in adults less than 65 years old
por: Wang, Dingding, et al.
Publicado: (2022)

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
por: Qualls, David, et al.
Publicado: (2023)

Effectiveness of statins in Medicare-eligible patients and patients < 65 years using clinical practice data*
por: Fox, K M, et al.
Publicado: (2007)

Comparison of clinical characteristics and outcomes of pyogenic liver abscess patients < 65 years of age versus ≥ 65 years of age
por: Zhang, Jia, et al.
Publicado: (2019)

DLBCL-Morph: Morphological features computed using deep learning for an annotated digital DLBCL image set
por: Vrabac, Damir, et al.
Publicado: (2021)

Incidence of airflow limitation in subjects 65–100 years of age
por: Luoto, Johannes A., et al.
Publicado: (2016)

Factors associated with the acceptance of employing nursing assistants aged 65 and older among those younger than 65 years old
por: Kudo, Yasushi, et al.
Publicado: (2023)

Mammographic screening after the age of 65 years: early outcomes in the Nijmegen programme.
por: van Dijck, J., et al.
Publicado: (1996)

P1117: GLOFITAMAB PLUS R-CHOP OR POLATUZUMAB VEDOTIN-R-CHP IS DELIVERABLE AND YIELDS HIGH OVERALL RESPONSE IN PATIENTS <=65 YEARS OF AGE WITH HIGH-RISK DLBCL OR HGBL: INTERIM ANALYSIS OF THE COALITION STUDY
por: Minson, Adrian, et al.
Publicado: (2023)

An extended Arctic proxy temperature database for the past 2,000 years
por: McKay, Nicholas P., et al.
Publicado: (2014)

Ureteral Diverticulum in 65-Year-Old Female
por: Abdullatif, Victor, et al.
Publicado: (2021)

Comparing neuromotor functions in 45- and 65-year-old adults with 18-year-old adolescents
por: Kakebeeke, Tanja H., et al.
Publicado: (2023)

Cardiac Involvement by HIV-Associated DLBCL
por: Mupamombe, Charles T., et al.
Publicado: (2018)

The Tumor Microenvironment of DLBCL in the Computational Era
por: Opinto, Giuseppina, et al.
Publicado: (2020)

Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age
por: Tesser, John, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_clbc1b8lm9ceoh0901da1im68s